CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.

@article{Pignolet2016CD62LTA,
  title={CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.},
  author={B{\'e}atrice SL Pignolet and Nicholas Schwab and Tilman Schneider-Hohendorf and Florence Bucciarelli and Damien Biotti and Delphine Averseng-Peaureaux and Olivier Outteryck and J C Ongagna and J{\'e}r{\^o}me de S{\'e}ze and Bruno Brochet and Jean-Christophe Ouallet and Marc Debouverie and Sophie Pittion and Gilles Defer and Nathalie Derache and Patrick Hautecoeur and Ayman Tourbah and Pierre Labauge and Giovanni Castelnovo and Pierre Clavelou and Eric Berger and Jean Pelletier and A Palomeque Rico and H{\'e}l{\`e}ne Z{\'e}phir and David Axel Laplaud and Sandrine Wiertlewski and William Camu and Eric Thouvenot and Olivier Casez and Thibault Moreau and Agn{\`e}s Fromont and Sandra Vukusic and Caroline Papeix and Patrick Vermersch and Manuel Comabella and Christine Lebrun-Fr{\'e}nay and Heinz Wiendl and David Brassat},
  journal={Neurology},
  year={2016},
  volume={87 23},
  pages={
          2491-2494
        }
}
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…